Please use a PC Browser to access Register-Tadawul
Get It
BRIEF-Axsome Therapeutics Q4 Net Income USD -28.559 Million
Axsome Therapeutics, Inc. AXSM | 156.08 | +1.27% |
Feb 23 (Reuters) - Axsome Therapeutics Q4 operating expenses USD 222.956 million.
